stock
4-(4-aminophenyl)-3-methyl-4-oxobutanoic acid is a specialized intermediate primarily utilized in the synthesis of complex pharmaceutical scaffolds. Its core manufacturing process involves precise condensation reactions under controlled catalytic conditions to ensure high purity and stereochemical integrity. The compound is characterized by the molecular formula C11H13NO3, though specific CAS registration data requires verification against current regulatory databases for this exact structural variant.
Strict adherence to safety protocols is mandatory during handling due to potential sensitization risks. Storage must be conducted in cool, dry environments away from strong oxidizers to prevent decomposition. Clinical application is restricted solely to research contexts until full toxicological profiles are established.